A GENERALIZED ACTION PLAN FOR OBSTETRIC HOSPITALS AND OUTPATIENT CLINICS DURING THE SUSPECTED OR CONFIRMED COVID-19 PANDEMIC


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This summary paper presents a generalized action plan for hospitals and outpatient clinics during the COVID-19 coronavirus pandemic. Now the pandemic is the most relevant global challenge. Taking into account that the medical world does not have much clinical experience with COVID-19 and other coronaviruses, such as SARS-CoV and MERS-CoV, thoroughness and caution in assessing and treating pregnant women is an extremely urgent topic. The authors of this article summarized the world experience in managing patients with coronavirus disease and brought it into a unique algorithm that was considered most rational.

Full Text

Restricted Access

About the authors

Stefano BETTOCCHI

University "Aldo Moro"

full professor, II Unit of obstetrics and gynecology at the Policlinico of Bary Bary, Italy

Attila VERETZKY

Versys Clinics

Email: Attila.vereczkey@versysclinics.com
professor, Founder and Medical director of the Human Reproduction Institute Budapest, Hungary

Dmitriy O. IVANOV

Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia

Doctor of Medical Sciences, professor, Chief Neonatologist of the Ministry of Health of Russia, Rector Saint Petersburg, Russia

William CONDO

Vita Batel hospital

professor Batel, Brazil

Kirill Yu. KRYLOV

Saint Petersburg I.I. Dzhanelidze Research Institute of Emergency Medicine

Email: drkrylov@mail.ru
PhD, candidate of medical sciences, researcher, obstetrician-gynecologist Saint Petersburg, Russia

Franco LISI

Altamedica

Email: Franco.lisi0l@gmail.com
professor, director of IVF Unit Roma, Italy

Felice PETRAGLIA

University of Florence

Email: petraglia@unifi.it
professor, president of society of endometriosis and uterine disorders, Obstetrics and gynecology Department Exp. Clinical Biomed. Sci. Firenze, Italy

Vitaly A. REZNIK

Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia

assistant professor, candidate of medical sciences, Head physician Saint Petersburg, Russia

Nikolai N. RUKHLYADA

Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia

Email: nickolasr@mail.ru
professor, Chief Researcher of the Department of Gynecology, I.I. Dzhanelidze Saint Petersburg Research Institute of Emergence Care; Head of the Department of Obstetrics and Gynecology with a Course of pediatric gynecology, Chief specialist, Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia Saint Petersburg, Russia

Sushila SAINI

Jaipur doorbeen hospital

Professor Jaipur, India

Daniel S. SANABRIA

University of the Andes

MD, gynecologist, Obstetrics and Human reproduction department Santa Fe de Bogota Foundation Bogota, Columbia

References

  1. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)» Версия 5. Утв. Министерством здравоохранения РФ 08.04.2020.
  2. Alserehi H., Wali G., Alshukairi A., Alraddadi B. Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect. Dis. 2016; 16: 105. https://dx.doi.org/10.1186/s12879-016-1437-y.
  3. Behzadi M.A., Leyva-Grado V.H. Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and Middle East respiratory syndrome coronavirus infections. Front. Microbiol. 2019; 10: 1327. https://dx.doi.org/10.3389/fmicb.2019.01327.
  4. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507-13. https:// dx.doi.org/10.1016/S0140-6736(20)30211-7.
  5. Chong Y.P., Song J.Y., Seo Y.B., Choi J.P., Shin H.S.; Rapid Response Team. Antiviral treatment guidelines for Middle East respiratory syndrome. Infect. Chemother. 2015; 47(3): 212-22. https://dx.doi.org/10.3947/ic.2015.47.3.212.
  6. World Health Organization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected: interim guidance. WHO/MERS/Clinical/15.1 Revision 1. WHO; 2019.
  7. Commonwealth of Australia. Department of Health. Novel coronavirus (2019-nCoV). Available at: https://www.health.gov.au/health-topics/novel-coronavirus-2019-ncov
  8. FDA. Novel coronavirus (2019-nCoV). Available at: https://www.fda.gov/ emergency-preparedness-andresponse/mcm-issues/novel-coronavirus-2019-ncov
  9. Federal Ministry of Health. Current information on the coronavirus. Available at: https://www.bundesgesundheitsministerium.de/en/en/press/2020/ coronavirus.html
  10. Gao J., Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends. 2020; 2020; 14(1): 72-3. https://dx.doi.org/10.5582/ bst.2020.01047.
  11. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Cinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. https://dx.doi.org/10.1016/S0140-6736(20)30183-5.
  12. Ji W., Wang W., Zhao X., Zai J., Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J. Med. Virol. 2020; 92(4): 433-40. https:// dx.doi.org/10.1002/jmv.25682.
  13. Jeong S.Y., Sung S.I., Sung J.H., Ahn S.Y., Kang E.S., Chang Y.S. et al. MERS-CoV infection in a pregnant woman in Korea. J. Korean Med. Sci. 2017; 32(10): 1717-20. https://dx.doi.org/10.3346/jkms.2017. 32.10.1717.
  14. Lei J., Li J., Li X., Qi X. CT Imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020; 295(1): 18. https://dx.doi.org/10.1148/ radiol.2020200236. Available at: https://pubs.rsna.org/doi/10.1148/ radiol.2020200236
  15. Chang L., Yan Y., Wang L. Coronavirus disease 2019: Coronaviruses and blood safety. Transfus. Med. Rev. 2020; Feb 21. pii: S0887-7963(20)30014-6. https:// dx.doi.org/10.1016/j.tmrv.2020.02.003.
  16. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 2020; 382(13): 1199-207. https://dx.doi.org/10.1056/ NEJMoa2001316.
  17. Li X., Zai J., Wang X., Li Y. Potential of large ‘first generation’ human-to-human transmission of 2019-nCoV. J. Med. Virol. 2020; 92(4): 448-54. https:// dx.doi.org/10.1002/jmv.25693.
  18. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci. Trends. 2020; 14(1): 69-71. https://dx.doi.org/10.5582/bst.2020.01020.
  19. National Health Commission of the People’s Republic of China. Available at: http://en.nhc.gov.cn
  20. Wu P., Hao X., Lau E.H.Y., Wong J.Y., Leung K.S.M., Wu J.T. et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020; 25(3). https://dx.doi.org/10.2807/1560-7917.ES.2020.25.3.2000044.
  21. Zhang L., Liu Y. Potential interventions for novel coronavirus in China. J. Med. Virol. 2020; 92(5): 479-90. https://dx.doi.org/10.1002/jmv.25707.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies